F 0610
Respond appropriately to all alleged violations.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, and record review, the facility failed to ensure a thorough investigation was conducted and
completed for missing narcotics for 1 of 1 resident of a total sample of 44 residents, (#76).
Residents Affected - Few
Findings:
Clinical record review revealed resident #76, a [AGE] year-old-male was admitted to the facility on [DATE].
His diagnoses included cellulitis to the right lower limb, peripheral vascular disease, chronic pain syndrome,
and dorsalgia.
Review of the resident's physician orders revealed an order dated [DATE] for Percocet 5-325 milligram (mg)
one tablet every six hours as needed for moderate pain. The order was discontinued on [DATE], and a new
order was noted for Percocet 5-325 mg one tablet every six hours
Review of the facility's Reportable log revealed an entry on [DATE] for misappropriation of property, and
documentation revealed twenty-four (24) tablets of Percocet 5-325 mg for resident #76 was unaccounted
for.
On [DATE] 4:23 PM, the incident was reviewed with the Administrator, the Director of Nursing (DON) and
the Social Services Director (SSD). The SSD explained she was responsible to complete the Agency For
Health Care Administration (AHCA) Nursing Homes Federal Reporting Immediate and 5-day reports, notify
the Ombudsman, and law enforcement of the incident, and submit the Department of Children and Family
(DCF) report. She stated the investigations for reportable incidents were done by the Interdisciplinary Team
(IDT). The AHCA Report #189603 Immediate, and 5-day was submitted by the facility on [DATE], and
[DATE] respectively. The DON recalled that on [DATE] at 6:45 PM, she was notified by the Clinical Care
Leader of a discrepancy in narcotic count where 24 tablets of Percocet for resident #76 were unaccounted
for. Actions taken by the facility included a search of the medication cart, and medication room was
conducted on Station 2. The resident's Medication Administration Record (MAR) was reviewed, a pharmacy
inquiry was made regarding delivery of the medication, staff present were interviewed, the Physician
Assistant was notified of the missing medication, and a prescription was obtained for pain medications for
the resident, which was replaced at the facility's expense. On [DATE], and on [DATE], a drug test was
performed for three nurses. Four remaining medication carts were searched for a total of five of five carts.
In-service was conducted with nursing staff regarding the Process of completion of the Controlled Drug
Record, and medication delivery process. Clinical leaders were to check the Controlled Drug Record daily
for completion. The DON stated the Pharmacy verified they delivered 30 Percocet tablets to the facility on
[DATE], and 120 tablets on [DATE]. She stated that initially the resident was on the medication every 6
hours as needed, but with the frequency of use, the medication was changed to one tablet every 6 hours
around the clock on [DATE].
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 11
Event ID:
105559
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0610
Level of Harm - Minimal harm
or potential for actual harm
The DON recalled the facility reviewed copies of drug receipts, and some signatures were not readable.
She said the investigation revealed narcotics were not being entered properly on the Controlled Drug
Record. She verbalized the facility could not identify when the resident's Percocet tablets went missing, and
they could not identify who was involved. She shared the Root Cause was due to varied staff, facility nurses
and Agency nurses, and a lack of oversight.
Residents Affected - Few
An Investigation Statement dated [DATE] and documented by the SSD, revealed the resident stated he had
not received his Percocet, and the SSD explained the facility had to report, and investigate the incident. No
other statements could be identified, and when asked about statements from the staff, the DON said she
did not see any other statements in her binder.
When asked if an Ad Hoc Quality Assurance Performance Improvement (QAPI) was completed, the DON
replied no, and said the Medical Director was made aware since he was the resident's physician. She
stated the incident was discussed in QAPI on [DATE]. They spoke about what was identified and spoke
about the education and process in place.
Review of the AHCA 5-day Report, revealed documentation to indicate the facility would conduct audits
weekly for four weeks, then monthly for two months. Review of the Controlled Medication Audit revealed
audits were completed on [DATE], [DATE], [DATE], [DATE], [DATE], [DATE], and [DATE]. The completion
instructions on the Audit form read, The DNS (Director of Nursing Service) or designee, to audit narcotic
procurement and counting daily x 1 week then 2 times weekly x 2 weeks then weekly x 4. Questions/probes
on the form were: Are controlled medications properly stored with double lock? Are appropriate medications
counted with change of shift each day with signatures to indicate no concerns? Are all medications
reviewed and signed in by the floor nurse with pharmacy courier when delivered? Narcotics that are
discontinued, or expired of a discharged resident are immediately destroyed and/or returned as
appropriate? A check mark should be in the yes or no column, and there was a column for any additional
comments. The DON stated the audits were completed for two weeks, then the Regional Clinical Nurse
directed the facility to discontinue the audits and change to probing questions. The audits did not address
the accurate completion of the Controlled Drug Record.
On [DATE] at 9:40 AM, the DON stated the facility could not prove the resident's medication was missing,
and the facility did not have copies of invoices for medications delivered.
Review of the Work with Order File provided by the facility, that was faxed from the Pharmacy on [DATE] at
5:04 PM, revealed the following: Oxycodone-Acetaminophen (Percocet): 5-325 Tab on [DATE], 30 tablets
were ordered and shipped to the facility. On [DATE] 12 tablets were ordered and shipped, on [DATE] 12
tablets were ordered, and was shipped on [DATE]. On [DATE], 12 tablets were ordered and shipped, and on
[DATE], 120 tablets were ordered and shipped to the facility. This revealed a total of 186 tablets of Percocet
5-325 mg was delivered to the facility between [DATE] to [DATE]. Review of the resident's MAR for the
period [DATE] to [DATE] revealed a total of 82 tablets were administered to the resident, and from [DATE]
until [DATE], 77 tablets were administered, a total of 159 tablets out of 186 tablets, leaving a balance of 27
tablets that were unaccounted for.
The Work with Order File from the pharmacy was requested by the facility after interviews with the
surveyor. The facility could not verify, and ensure an accurate inventory, and accounting of the Percocet
received and administered for resident #76 prior to [DATE].
On [DATE] at 4:05 PM, the investigation was discussed with the DON, regarding missing statements from
staff, and follow-up with the pharmacy. The DON said there was a lack all around and confirmed
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 2 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0610
that a thorough investigation was not done.
Level of Harm - Minimal harm
or potential for actual harm
The facility's policy Abuse And Neglect-Rehab/Skilled, Therapy & Rehab reviewed and revised on [DATE],
read, The investigation may include interviewing employees . Interview all involved (employee, resident and
family) .Consider having each person write his or her memory of the event. If possible, get signed and
dated statements from any witnesses.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 3 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
PASARR screening for Mental disorders or Intellectual Disabilities
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, and record review, the facility failed to ensure a Preadmission Screening and Resident Review
(PASRR) was completed to evaluate the need for additional mental health resources and appropriate
placement of a resident prior to admission for 1 of 1 residents reviewed for PASRRs of a total sample of 44
residents, (#29).
Residents Affected - Few
Findings:
Resident #29 was admitted to the facility on [DATE] from an Assisted Living Facility with diagnoses that
included unspecified dementia, Bipolar disorder, and Major Depressive Disorder.
Review of the Minimum Data Set (MDS) admission assessment dated [DATE] section A1500 (PASRR)
coded O which incorrectly indicated resident #29 did not have a serious mental illness and/or an intellectual
disability according to the stated level II PASRR. Review of the MDS Section I, Active Diagnosis revealed
resident #29 was diagnosed with Non-Alzheimer's dementia and Manic depression/Bipolar disease.
A Psychology Evaluation Note dated 3/07/23 revealed resident #29 reported recurrent, mild depressive
symptoms which included trouble concentrating, fatigue, decreased self-esteem, a lack of pleasure and a
loss of interest in activities she normally found pleasurable. The psychologist described resident #29 as
having mild cognitive impairment with a psychiatric history of depression, anxiety and episodic mood
difficulties.
Review of resident #29's medical record revealed no documentation of a level I PASRR, nor a level II
PASRR in her record.
On 2/01/24 at 10:48 AM, the Social Service Director described a level I PASRR was used during
pre-admission to assess a possible resident's mental, physical and psychological abilities to determine if a
resident with psychiatric history was appropriate for the long-term care or skilled nursing setting. She
explained the screening also determined if a resident needed further screening for additional specialized
services for their serious mental illness or intellectual disability. The Social Service Director stated the
PASRR screenings were important to help meet the residents' needs, properly develop their plan of care
and ensure the resident would be the right fit for the facility. She further explained the level I PASRR was
supposed to be completed before admission to the facility, and if a resident was found without screening
completed, she would be tasked to complete it.
On 1/31/24 at 2:36 PM, the station 1 Unit Manager (UM) stated she was not able to find a level I nor a level
II PASRR in resident #29's medical records. She confirmed resident #29 had a psychiatric history and
should have had a level I PASRR on admission. She was unsure if resident #2 required a level II PASRR.
About an hour later at 3:28 PM, the station 1 UM confirmed the facility could not provide documentation of
a level I nor a level II PASRR for resident #29. She explained that because the level I screening had not
been done, the Social Service Director had just completed one which indicated resident #28 had a serious
mental illness and required a level II PASRR which was to be scheduled.
On 2/01/24 at 9:51 AM, the Social Service Director stated the level I PASRR was usually included in the
paperwork that came from the hospital but if a resident was admitted from home or from an
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 4 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Assisted Living facility like resident #29, they usually would not have one performed prior to admission. She
explained the previous Health Information Management (HIM) supervisor had done audits on all new
admissions to check the needed paperwork, but she was not sure who, if anyone was currently responsible
for that task.
On 2/01/24 at 10:26 AM, the current HIM supervisor stated she was unaware of any audits of new
admission documents by the previous supervisor nor of any problem with missing PASRR screenings. She
explained she assumed nurses were responsible to ensure the correct paperwork was included in the
admission documents and that they should notify the Social Service Director if the screening was needed.
The HIM supervisor stated a facility wide audit was needed to ensure all applicable residents had a PASRR
completed.
On 2/01/24 at 3:18 PM, the Social Service Director stated they had not started an audit to determine how
many residents were missing the PASRR, but she could see from her notebook at least five other residents
who came from home were missing them. The Social Service Director stated this was a problem.
Review of the job description, Health Information Management Technician, Long Term Care dated 11/13/23
revealed the employee would understand regulatory standards for accurate medical records. They would
also complete admission-related functions including retrieval of previous medical records.
The Pre-admission Screening and Resident Review policy dated 12/11/23 described the purpose to
determine admission criteria for residents with mental illness and ensure those individuals would receive
the care and services needed in the most appropriate setting. The policy defined serious mental illness to
include mood, or severe anxiety disorders and others. The document indicated, All prospective residents
will be screened for possible serious mental disorders or intellectual disabilities and related conditions. The
policy further detailed a positive level I screen necessitated an, in-depth evaluation of the individual, known
as a PASRR level II conducted by a state- designated authority prior to admission.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 5 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, and record review, the facility failed to ensure accurate record for receipt and disposition of
controlled medications was completed to enable accurate reconciliation, and to account for missing
Percocet tablets for 1 of 1 resident of a total sample of 44 residents, (#76).
Findings:
Clinical record review revealed resident # 76 a [AGE] year-old-male was admitted to the facility on [DATE].
His diagnoses included cellulitis to the right lower limb, peripheral vascular disease, chronic pain syndrome,
and dorsalgia
Review of the resident's physician orders revealed an order dated 3/09/23 for Percocet 5-325 milligram
(mg) one tablet every six hours as needed for moderate pain. The order was discontinued on 9/26/23, and a
new order was noted for Percocet 5-325 mg one tablet every six hours.
Review of the facility's Reportable log revealed an entry on 10/20/23 for misappropriation of property, and
documentation revealed twenty-four (24) tablets of Percocet 5-325 mg for resident #76 was unaccounted
for.
On 1/30/24 at 4:23 PM, the incident was discussed with the Administrator, the Director of Nursing (DON,
and the Social Services Director (SSD). The SSD explained she was responsible to complete the Agency
For Health Care Administration (AHCA) Nursing Homes Federal Reporting Immediate and 5-day reports,
notify the ombudsman, and law enforcement of the incident, and submit the Department of Children and
Family (DCF) report. She stated the investigations for reportable incidents was done by the Interdisciplinary
Team (IDT). The DON recalled on 10/20/23 at 6:45 PM, she was notified by the Clinical Care Leader of a
discrepancy in narcotic count, and that 24 Percocet tablets were missing for resident #76. The DON stated
a search of the medication cart, the medication room on Station 2, and the remaining four medication carts
in the facility was conducted. The resident's Medication Administration Record (MAR) was reviewed, staff
on duty at the time were interviewed, and an inquiry was made to the Pharmacy regarding delivery of the
medication. She stated the Physician Assistant was made aware, and a prescription was obtained for pain
medication for the resident, to be replaced at the facility's expense. The DON stated the Pharmacy
confirmed delivery of Percocet for the resident on 9/22/23 of 30 tablets, and on 9/26/23, of 120 tablets. She
stated that initially, the resident was on Percocet every 6 hours as needed, but with the frequency of use,
the medication was then changed on 9/26/23, and scheduled for every 6 hours around the clock. The DON
recalled the resident's MAR reviewed for the period 9/17/23 to 9/25/23, and 9/26/23 to 10/20/23, revealed
the resident received Percocet 5-325 mg every 6 hours, and the facility verified that 24 tablets of Percocet
were missing. She stated no medication was available for the resident on investigation, and to address the
resident's pain, the facility called the physician, and the pharmacy, and the facility assumed payment for the
medication sent by pharmacy, and an authorization code was received from the pharmacy to retrieve the
medication from their onsite emergency medication dispenser for immediate administration. The DON
stated drug test was performed on 10/21/23, and on 10/23/23, on three nurses who worked the 7 AM to 7
PM, and 7 PM to 7 AM shifts and results were all negative. She said statements were obtained from the
nurses; however, the facility could not provide documentation of the statements. The DON recalled the
facility reviewed copies of drug receipt, and some signatures were not readable. She said the investigation
revealed narcotics were not being entered properly on the Controlled Drug Record. The DON
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 6 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
verbalized the facility could not identify when the resident's Percocet tablets went missing, and they could
not identify who was involved. She shared the Root Cause was due to varied staff, facility nurses and
Agency nurses, and a lack of oversight. She stated in-service education to address the delivery of narcotics
was initiated, and staff were educated that two nurses must receive and sign the receipt for the drug and
obtain a copy of the receipt. The DON said audits were started on 10/25/23 to 10/30/23, however, no
documentation could be identified to indicate the Controlled Drug Record, the Controlled Medication
Utilization Record were checked, and reconciled with the medication packets. She stated the Pharmacy
Consultant did not review the resident's Controlled Medication Utilization Record, but she was informed by
the Consultant Pharmacist, that the incident was discussed at the Pharmacy Corporate level.
On 1/30/24 at 5:16 PM, Licensed Practical Nurse (LPN) A confirmed that he cared for resident #76 on
10/20/23. He recalled the resident was scheduled to receive Percocet 5-325 mg but when he checked the
medication cart, there was no Percocet for the resident. LPN A stated he called the pharmacy and was told
three packets of Percocet for resident #76 had been delivered to the facility. He recalled he informed the
pharmacy there was no Percocet and was told the Pharmacy could not dispense any more. The LPN said
the supervisor followed up with the pharmacy and was told the pharmacy could not send any more
Percocet. LPN A stated the supervisor reviewed the resident's narcotic sheet, and at first thought the
Percocet was missing, but it was a miscalculation of the medication, and no medication card was missing.
On 1/31/24 at 9:40 AM, the DON stated that initially, the facility thought 24 tablets of Percocet were missing.
She said the pharmacy had sent 120 tablets on 9/26/23. She stated the facility could not prove the
medication was missing. The Controlled Medication Utilization Record for the resident was reviewed with
the DON. On 9/15/23, and on 9/22/23, 12 tablets of Percocet 5-325 mg was received and administered
leaving a balance of 0 on the respective Records. On 9/26/23, 120 tablets of Percocet 5-325 mg was
received. Between 9/28/23 to 10/05/23, 30 tablets were administered. A Controlled Medication Utilization
Record for resident #76 could not be identified for the period 9/23/23 to 9/25/23, and for the period 10/06/23
to 11/05/23. The DON stated the records could not be found, verbalizing there was an issue with missing
records in the Health Information Management (HIM). Based on information reviewed on the resident's
Controlled Medication Utilization Records, a total of 144 tablets of Percocet 5-325 mg was received by the
facility between 9/15/23 to 9/26/23. Review of the resident's Medication Administration Record (MAR)
revealed documentation to indicate the resident received Percocet 5-325 mg on 9/23/23 at 12:34 AM, at
12:45 PM, and at 6:45 PM. On 9/24/23 at 7:14 PM, and on 9/25/23 at 11:00 AM, and 11:15 PM. The
resident's Controlled Medication Utilization Record for this period could not be found. As per the DON,
doses were obtained from their onsite emergency medication dispenser with authorization. Review of the
resident's MARs from 10/05/23 to 10/20/23 revealed 41 tablets of Percocet 5-325 mg was administered to
the resident. The total amount of Percocet tablets administered to the resident based on review of
Controlled Medication Utilization Records, and his MAR for the period 9/01/23 to 10/20/23 was 125. From
9/15/23, to 9/26/23, 144 tablets of Percocet was delivered to the facility, which indicated nineteen (19)
tablets were unaccounted for. This was confirmed by the DON. She said the facility did not know if the
medication was sent by the pharmacy, since the facility did not have any paperwork to prove the delivery.
She stated the facility did not have copies of the invoices for the medications delivered. The DON stated the
Controlled Drug Record was not completed accurately by the nurses when narcotics were received, so the
facility could not account for medications received, or the name of the resident the medication was for. She
stated the incident was discussed in the facility's Quality Assurance Performance Improvement (QAPI)
meeting on 11/25/23. They spoke about what was
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 7 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
identified, and the education and process in place. The DON stated the allegation was not substantiated,
because the facility did not have any proof that the resident's Percocet tablets were missing, as there was a
lack of documentation. She said they were unable to prove what was on hand, and what was missing, and
said there must be paperwork somewhere, but the facility did not have it.
On 1/31/24 at 10:32 AM, the Administrator stated that review of the report of medications retrieved from the
onsite emergency medication dispenser revealed no medication was retrieved for the period 9/20/23 to
9/24/23. The facility was unable to explain where the medication documented on the MAR as administered
to the resident on the dates mentioned was obtained.
On 01/31/24 12:16 PM, Registered Nurse (RN) D, recalled it was on a Friday night in October 2023, the
Administrator called her and said she had to come to the facility within twenty-four to forty-eight hours for a
drug test as some narcotics were missing. RN D stated she came to facility and had the test done, and it
was negative. She said she was not told which resident's narcotic was missing, only that some Percocet
were missing for a resident she was assigned to.
On 01/31/24 at 2:15 PM, resident #76 stated he recalled when he could not get his medication, because it
was not in the medication cart, and the nurse did not know the code for the emergency dispenser. When
asked if he was told why the medication was not available, the resident said it was because the nurse did
not have a code.
Review of the Work with Order File provided by facility, that was faxed from the Pharmacy on 1/31/24 at
5:04 PM revealed the following: Oxycodone-Acetaminophen (Percocet): 5-325 Tab that on 9/05/23 30
tablets were ordered and shipped to the facility. On 9/15/23 12 tablets were ordered and shipped, on
9/17/23 12 tablets were ordered, and was shipped on 9/18/23. On 9/22/23, 12 tablets were ordered and
shipped, and on 9/26/2023, 120 tablets were ordered and shipped to the facility. This revealed a total of 186
tablets of Percocet 5-325 mg was delivered to the facility between 9/05/23 to 9/26/23. Review of the
resident's MAR for the period 9/01/23 to 9/30/23 revealed a total of 82 tablets were administered to the
resident, and from 10/01/23 up until 10/20/23, 77 tablets were administered, a total of 159 tablets out of 186
tablets, leaving a balance of 27 tablets that were unaccounted for.
The Work with Order File from the pharmacy was requested by the facility after interviews with the
surveyor, hence the facility could not verify, and ensure an accurate inventory, and accounting of the
Percocet received and administered for resident #76 prior to 1/31/24.
The facility's policy Medications: Controlled reviewed and revised on 6/13/2023 documented purpose was,
To provide verification and reconciliation of all controlled medications Reconciliation: refers to a system of
recordkeeping that ensures as accurate inventory of medications by accounting for controlled medications
that have been received, dispensed, administered and/or including the process of disposition.
The policy Medication: Missing/Diversion of Medications reviewed/revised on 9/18/2023 outlined the steps
to be taken by the facility in the event of missing/diverted medications, and directs that an investigation
should be performed, and the facility should work closely with the pharmacy staff to prove when and what
amount of the medication was sent to the location.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 8 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to act on PRN (as needed) psychotropic
medication duration limits for 2 of 5 residents reviewed for Unnecessary Medications from a total sample of
44 residents, (#91, #98).
Findings:
1. Review of the medical record revealed resident #98, a [AGE] year old male was admitted to the facility on
[DATE] and re-admitted from an acute care hospital on [DATE] with diagnoses that included cerebral
vascular accident (stroke), aphasia (inability to formulate speech), dementia, lack of coordination, type 2
diabetes mellitus, and unsteadiness on feet.
The Minimum Data Set (MDS) quarterly assessment with Assessment Reference Date (ARD) 8/03/23
identified the resident was unable to complete a Brief Interview for Mental Status (BIMS), was rarely or
never understood, noted by staff to have short-term and long-term memory problems, severely impaired
cognitive decision making abilities, disorganized thinking that fluctuated and changed in severity, and he
had no behaviors or rejections of care. The assessment showed the resident required assistance from staff
to complete Activities of Daily Living (ADLs), mobility functions in and out of bed, and to walk; he fell two or
more times, and he received high risk antipsychotic and antianxiety medications five out of seven days, and
antidepressant medication for seven out of seven days during the look-back period.
The Comprehensive Care Plan Focus included communication problems related to expression of thoughts,
behavior symptoms, grief, risk for acute pain, ADL self-care deficits, history of falls, and risk for injuries from
falls.
On 1/29/24 at 11:20 AM, resident #98 was observed on the nursing unit sitting at a group table of four. He
was not able to verbally communicate. On 1/30/24 at 3:01 PM, the resident was observed walking in the
hallway using a walker, assisted and supervised by two facility staff.
Review of the Electronic Health Record (EHR) showed from 7/11/23 to 8/15/23, PRN medication orders
were implemented for Lorazepam (anti-anxiety), Benadryl (antihistamine), and Haldol (anti-psychotic) 1
Milliliter (ml) combined in a transdermal (absorbed through the skin) gel for anxiety, every four hours. The
Medication Administration Record (MAR) documented nurses administered the medication 27 times, over
36 days. From 8/15/23 to 9/05/23, PRN orders were implemented for Ativan (anti-anxiety) 1 milligram (MG)
transdermal gel for anxiety, every four hours. The MAR documented nurses administered the medication 9
times, over 21 days. From 9/12/23 to 10/10/23, orders were implemented for Ativan (anti-anxiety) 0.5 MG
transdermal gel for anxiety, every six hours. The MAR documented nurses administered the medication 8
times, over 28 days.
The August 2023 Pharmacy Consultant Report read, resident has a PRN order for an anxiolytic, without a
stop date: Ativan gel . Rationale for Recommendation: CMS (Centers for Medicare and Medicaid Services)
requires that PRN orders for non-antipsychotic psychotropic drugs be limited to 14 days.
On 2/01/24 at 3:26 PM, the Director of Nursing (DON) explained the facility's process for ensuring
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 9 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
PRN psychotropic medications had a 14-day duration limit included reconciliation reviews upon resident
admissions, psychiatric provider assessments, nursing management tracking, and monthly Medication
Regimen Review (MRR) reports. She checked resident #98's medical record, and acknowledged there
were three PRN psychotropic medication orders in place from 7/11/23 to 10/10/23 that were not reviewed
by nursing management while they had extended well beyond the 14-day limit. She said she had only been
working at the facility for three months and stated, there should have been a 14 day stop date.
In a joint telephone interview with the DON and the facility's Pharmacy Consultant on 2/1/24 at 3:47 PM,
the Pharmacy Consultant stated reports were submitted to the facility every month with recommendations
that included orders that showed PRN psychotropic medication orders that were missing a stop date. He
explained, the use of PRN anti-anxiety and anxiolytics were high-risk, especially in the elderly and they
required special monitoring for over-use because they could mask other underlying root causes.
2. Resident #91, [AGE] year-old female, was admitted to the facility on [DATE] with diagnosis of Alzheimer's
Disease, anxiety disorder, major depressive disorder, and persistent mood disorder.
Review of the resident's Minimum Data Set (MDS) Quarterly assessment with assessment reference date
of 11/10/23 revealed resident #91 had severely impaired cognitive skills for daily decision making. She had
indicators of behavior symptoms and rejection of care with no indicators of psychosis. She was dependent
on staff for her Activities of Daily Living (ADLs) and received antianxiety and antidepressant medications.
Review of resident #91's discontinued/completed physician orders dated 5/2/23 noted Ativan Transdermal
Gel 1 milligram (mg) every four hours as needed (PRN) for anxiety with a discontinue date of 8/15/23.
Further review of the medical record revealed the physician did not provide a rationale for the extended
time frame for Ativan beyond the 14-day use. Review of the Medication Administration Record (MAR)
reflected the resident received 10 doses of Ativan Gel PRN beyond the 14 days.
Review of the Pharmacy Consultation Report dated 5/15/23 noted resident # 91 had a PRN order for
Lorazepam (Ativan) 1 milligram (mg) without a stop date. It was recommended to document the intended
duration of therapy, and the rationale for the extended time frame. The rationale for the recommendation
indicated CMS requires that PRN orders for non-antipsychotic drugs be limited to 14 days unless the
prescriber documents the diagnosed specific condition being treated, the rationale for the extended time
period, and the duration for the PRN order.
Review of the resident's active physician orders revealed resident #91 had an active order since 10/26/23
for Ativan Transdermal Gel 0.5 milligram (mg) every twelve hours as needed (PRN) for anxiety. Further
review of the medical record revealed the physician did not provide a rationale for the extended time frame
for Ativan beyond the 14-day use and did not indicate a specific duration or stop date. The resident's MAR
showed he received 17 doses of Ativan Gel PRN beyond the 14 days.
On 02/01/24 at 3:26 PM the DON stated that anxiolytics prescribed as needed (PRN) should receive a 14
day stop date. She stated resident # 91 had Ativan Gel prescribed as needed (PRN) on 5/2/23 with a stop
date of 8/15/23. She stated it should have had a 14 day stop date and the resident should not have
received the medications past the 14 days. The DON also acknowledged the resident had an active order
for Ativan Gel as needed (PRN) since 10/26/23. She stated there should have been a 14 day stop date and
the resident should not have received the Ativan Gel PRN past 14 days unless the provider noted a
rationale and duration for the extended time frame.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105559
If continuation sheet
Page 10 of 11
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105559
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Good Samaritan Society-Kissimmee Village
1500 Southgate Drive
Kissimmee, FL 34746
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
On 02/01/24 at 3:47 PM, the Pharmacist stated that Anxiolytics prescribed as needed (PRN) need a stop
date of 14 days or a rationale with the duration of the extended time period noted. He stated the Ativan
given to the resident on an as needed basis ought to have been limited to a 14-day duration.
The facility's standards and guidelines dated 2/10/23 and titled, Medication: Drug Regimen Review read,
PURPOSE To prevent medication errors that could cause harm to a resident or result in resident
hospitalization. To identify the potential for adverse events. pharmacists and nurses play a vital role in
improving health care .
Event ID:
Facility ID:
105559
If continuation sheet
Page 11 of 11